Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Semaglutide attenuates neuroinflammation in male mice.

Nature communications·2026
Same author

Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.

Diabetes, obesity & metabolism·2026
Same author

Correction: Comorbidities predict institutionalization and mortality in biomarker-confirmed alzheimer's disease.

Alzheimer's research & therapy·2026
Same author

Diagnosis, prognostic prediction of the accelerated phase of chronic lymphocytic leukaemia: a narrative review.

Contemporary oncology (Poznan, Poland)·2026
Same author

Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE).

Diabetes, obesity & metabolism·2026
Same author

Utilization and Lifetime Costs of Formal Care for Alzheimer's Disease Dementia in Sweden.

PharmacoEconomics·2026

相关实验视频

Updated: Jul 4, 2025

Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory
08:08

Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory

Published on: June 18, 2014

27.1K

在RBANS延迟记忆指数上重新选? 忘记了这些!

Marwan N Sabbagh1, Wojciech Michalak2, Charlotte Thim Hansen3

  • 1Department of Neurology, Barrow Neurological Institute, Phoenix, AZ.

Alzheimer disease and associated disorders
|January 26, 2024
PubMed
概括
此摘要是机器生成的。

重新选阿尔茨海默氏症患者最初在神经心理状态延迟记忆指数 (RBANS DMI) 评估重复电池上的得分较低,具有有限的价值. 大多数患者没有表现出显著的认知衰退,也没有满足进一步评估的标准.

更多相关视频

A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets
08:45

A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets

Published on: December 5, 2014

9.2K
Using Rapid Serial Visual Presentation to Measure Set-Specific Capture, a Consequence of Distraction While Multitasking
05:58

Using Rapid Serial Visual Presentation to Measure Set-Specific Capture, a Consequence of Distraction While Multitasking

Published on: August 29, 2018

8.9K

相关实验视频

Last Updated: Jul 4, 2025

Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory
08:08

Eye Tracking, Cortisol, and a Sleep vs. Wake Consolidation Delay: Combining Methods to Uncover an Interactive Effect of Sleep and Cortisol on Memory

Published on: June 18, 2014

27.1K
A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets
08:45

A Dual Task Procedure Combined with Rapid Serial Visual Presentation to Test Attentional Blink for Nontargets

Published on: December 5, 2014

9.2K
Using Rapid Serial Visual Presentation to Measure Set-Specific Capture, a Consequence of Distraction While Multitasking
05:58

Using Rapid Serial Visual Presentation to Measure Set-Specific Capture, a Consequence of Distraction While Multitasking

Published on: August 29, 2018

8.9K

科学领域:

  • 神经科学是一个神经科学.
  • 老年学是一门学科.
  • 临床心理学 临床心理学

背景情况:

  • 阿尔茨海默病 (AD) 诊断依赖于认知评估.
  • 神经心理状态延迟记忆指数 (RBANS DMI) 的可重复电池评估是一个关键的认知指标.
  • 重新查边界RBANS DMI得分的患者的实用性尚未得到充分证实.

研究的目的:

  • 评估重新查阿尔茨海默病患者的临床价值,这些患者最初不符合RBANS DMI的纳入标准.
  • 为了确定最初的RBANS DMI得分是否预测未来的认知能力下降或生物标志物阳性.

主要方法:

  • 来自欧洲预防阿尔茨海默氏症痴呆症数据库的数据分析.
  • 包括50-85岁没有痴呆症的参与者,迷你精神状态检查得分≥22,和基线粉样蛋白状况.
  • 利用重复测量和后勤回归的混合效应模型来分析RBANS DMI得分的变化和进展.

主要成果:

  • 观察到RBANS DMI得分随时间变化的显著变化.
  • 大约15%的参与者基线RBANS DMI得分在86-95之间,在6个月后进展到≤85.
  • 在那些进展的患者中,8%的人还符合临床痴呆症评分总分≥0.5的标准,5%是粉样蛋白阳性.

结论:

  • 仅根据最初的RBANS DMI得分重新选患者具有有限的诊断或预后价值.
  • 这些发现表明,目前针对阿尔茨海默病的重新选协议可能无法优化,对于边界初始认知测试结果的患者来说.